On February 13, 2025, David Williams, Executive Vice President, Chief Information and Digital Officer at Merck & Co Inc, sold 6,000 shares of the company. Following this transaction, the insider now owns 24,123.316 shares of Merck & Co Inc. Merck & Co Inc (MRK, Financial) is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. The company is committed to improving health and well-being around the world. The insider transaction history for Merck & Co Inc indicates that there have been two insider buys and five insider sells over the past year. This recent sale by David Williams is part of the ongoing insider activity within the company. On the day of the transaction, shares of Merck & Co Inc were trading at $85.34, giving the stock a market cap of $213.551 billion. The company's price-earnings ratio stands at 12.54, which is lower than the industry median of 21.86 and also below the company's historical median price-earnings ratio. With a trading price of $85.34 and a GF Value of $115.97, Merck & Co Inc has a price-to-GF-Value ratio of 0.74. This suggests that the stock is modestly undervalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as the price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's past returns and growth, and future estimates of business performance from Morningstar analysts. For more details on this transaction, refer to the SEC Filing.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
